Differential response to antidepressants in melancholic and severe depression

Psychiatric Annals

Volumn 28, Issue 2, 1998, Pages 84-88

  Nobler, Mitchell S ^a,b   Roose, Steven P ^a  

^a Columbia University ^*  (United States)

^b Department of Biological Psychiatry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032375183     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19980201-09     Document Type: Article

References (27)

1. Glassman AH, Perel JM, Shostak M, et al. Clinical implications of imipramine plasma levels for depressive illness. Arch Gen Psychiatry. 1977; 34:197-204.
2. Chan CH, Janicak PG, Davis JM, et al. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry. 1987; 48:197-200.
3. Spiker DG, Weiss JC, Dealy RS, et al. The pharmacological treatment of delusional depression. Am J Psychiatry. 1985; 142:430-436.
4. Carney MWP, Roth M, Garside RF. The diagnosis of depressive syndromes and the prediction of ECT response. Br J Psychiatry. 1965; 111:659-674.
5. Liebowitz MR, Quitkin FM, Stewart JW, et al. Antidepressant specificity in atypical depression. Arch Gen Psychiatry. 1988; 45:129-137.
6. Quitkin FM, Stewart JW, McGrath PJ, et al. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. Am J Psychiatry. 1988; 145:306-311.
7. Kiloh LG, Ball JRB, Garside RF. Prognostic factors in treatment of depressive states with imipramine. Br Med J. 1962; 1:1225-1229.
8. Reisby N, Gram LF, Bech P, et al. Imipramine: clinical effects and pharmacokinetic variability. Psychopharmacology. 1977; 54:263-272.
9. Gibbons RD, Clark DC, Davis JM. A statistical model for the classification of imipramine response in depressed inpatients. Psychopharmacology. 1982; 78:185-189.
10. Abou-Saleh MT, Coppen A. Classification of depression and response to antidepressive therapies. Br J Psychiatry. 1983; 143:601-603.
11. Paykel ES, Hollyman JA, Freeling P, et al. Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. J Affect Disord. 1988; 14:83-95.
12. Coryell W, Turner R. Outcome with desipramine therapy in subtypes of nonpsychotic major depression. J Affect Disord. 1985; 9:149-154.
13. Rush AJ, Giles DE, Jarrett RB, et al. Reduced REM latency predicts response to tricyclic medication in depressed outpatients. Biol Psychiatry. 1989; 26:61-72.
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23:56-62.
15. Parker G, Hadzi-Pavlovic D, Hickie I, et al. Sub-typing depression, III: development of a clinical algorithm for melancholia and comparison with other diagnostic measures. Psychol Med. 1995; 25:833-840.
16. Parker G, Hadzi-Pavlovic D, Wilhelm K, et al. Defining melancholia: properties of a refined sign-based measure. Br J Psychiatry. 1994; 164:316-326.
17. Glassman AH, Schildkraut JJ, Orsulak PJ, et al. Tricyclic antidepressants - blood level measurements and clinical outcome: an APA Task Force Report. Am J Psychiatry. 1985; 142:155-162.
18. Roose SP, Glassman AH, Walsh BT, et al. Tricyclic nonresponders: phenomenology and treatment. Am J Psychiatry. 1986; 143:345-348.
19. Danish University Antidepressant Group. Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology. 1986; 90:131-138.
20. Danish University Antidepressant Group. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord. 1990; 18:289-299.
21. Tignol J, Stoker MJ, Dunbar GC. Paroxetine in the treatment of melancholia and severe depression. Intl Clin Psychopharmacol. 1992; 7:91-94.
22. Beasley CM Jr, Holman SL, Potvin JH. Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial. Ann Clin Psychiatry. 1993; 5:199-207.
23. Heiligenstein JH, Tollefson GD, Faries DE. A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia. Intl Clin Psychopharmacol. 1993; 8:247-251.
24. Richelson E. Biological basis of depression and therapeutic relevance. J Clin Psychiatry. 1991; 52(6, suppl):4-10.
25. Roose SP, Glassman AH, Attia E, et al. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry. 1994; 151:1735-1739.
26. Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 1996; 153:985-992. Abstract.
27. Finkel SI. Double-blind comparison of sertraline and nortriptyline in late-life depression. 148th Annual Meeting of the American Psychiatric Association; Miami, Fla; May 20-25, 1995. Abstract.